Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.2059
+0.0053 (2.64%)
Apr 7, 2026, 3:04 PM EDT - Market open
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $21.54 million as of April 7, 2026. Its market cap has decreased by -55.38% in one year.
Market Cap
21.54M
Enterprise Value
49.20M
1-Year Change
-55.38%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has decreased from $97.37M to $21.54M, a decrease of -77.88%. That is a compound annual growth rate of -14.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 20.99M | -79.28% |
| Dec 31, 2025 | 101.30M | 115.21% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Plus Therapeutics | 22.85M |
| Tempest Therapeutics | 22.81M |
| NanoViricides | 21.81M |
| Vistagen Therapeutics | 21.50M |
| Curis | 21.31M |
| Tevogen Bio Holdings | 20.72M |
| Cocrystal Pharma | 20.68M |
| Quantum BioPharma | 20.31M |